» Articles » PMID: 33856821

Correlates of the Nicotine Metabolite Ratio in Alaska Native People Who Smoke Cigarettes

Overview
Specialty Pharmacology
Date 2021 Apr 15
PMID 33856821
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Research on nicotine metabolism has primarily focused on white adults. This study examined associations between nicotine metabolism, tobacco use, and demographic characteristics among Alaska Native adults who smoke cigarettes. Participants ( = 244) were Alaska Native adults who smoked and who provided a plasma sample at baseline (70.1%) or follow-up (29.9%) of a randomized controlled trial of a cardiovascular risk behavior intervention. At baseline, participants self-reported age, sex, Alaska Native heritage, cigarettes per day, time to first cigarette upon wakening, menthol use, perceived difficulty staying quit, tobacco withdrawal symptoms, and past-month tobacco product use, binge drinking, and cannabis use. At 3-, 6-, 12-, and 18-month follow-ups, participants self-reported 7-day point prevalence abstinence from smoking. Height and weight were measured to calculate body mass index (BMI). Participants' nicotine metabolite ratio (NMR), calculated as the ratio of plasma cotinine and trans-3' hydroxycotinine, was log-transformed. The sample (52.0% male, age = 47.0 years [ = 13.8], 60.3% of Inupiaq heritage) averaged 12.5 cigarettes per day ( = 10.5); 64.0% smoked within 30 min of wakening. NMR was not significantly associated with age, sex, Alaska Native heritage, BMI, cigarettes per day, time to first cigarette upon wakening, menthol use, perceived difficulty staying quit, past-month dual tobacco product use, withdrawal symptoms, past-month binge drinking, past-month cannabis use, or abstinence from smoking (all -values > .050). Characteristics that relate to NMR in Alaska Native adults may differ from those typically identified among white adults. Specifically, results may suggest that Alaska Native adults with slower nicotine metabolism do not titrate their nicotine intake when smoking. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

Citing Articles

Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion.

Tomaz P, Goncalves T, Santos J, Scholz J, Abe T, Gaya P Front Pharmacol. 2022; 13:900112.

PMID: 35935834 PMC: 9354088. DOI: 10.3389/fphar.2022.900112.


Exploring Potential for a Personalized Medicine Approach to Smoking Cessation With an American Indian Tribe.

Carroll D, Murphy S, Meier E, Rhodes K, Dorr C, Braaten G Nicotine Tob Res. 2022; 25(1):120-126.

PMID: 35661899 PMC: 9717394. DOI: 10.1093/ntr/ntac141.

References
1.
Chenoweth M, Novalen M, Hawk Jr L, Schnoll R, George T, Cinciripini P . Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers. Cancer Epidemiol Biomarkers Prev. 2014; 23(9):1773-82. PMC: 4154993. DOI: 10.1158/1055-9965.EPI-14-0427. View

2.
Binnington M, Zhu A, Renner C, Lanier A, Hatsukami D, Benowitz N . CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people. Pharmacogenet Genomics. 2012; 22(6):429-40. PMC: 3349071. DOI: 10.1097/FPC.0b013e3283527c1c. View

3.
Benowitz N, Jacob 3rd P, Jones R, Rosenberg J . Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther. 1982; 221(2):368-72. View

4.
Hughes J, Hatsukami D . Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986; 43(3):289-94. DOI: 10.1001/archpsyc.1986.01800030107013. View

5.
Liakoni E, Edwards K, St Helen G, Nardone N, Dempsey D, Tyndale R . Effects of Nicotine Metabolic Rate on Withdrawal Symptoms and Response to Cigarette Smoking After Abstinence. Clin Pharmacol Ther. 2018; 105(3):641-651. PMC: 7967935. DOI: 10.1002/cpt.1238. View